Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)-N-(3,3,3-[18F]trifluoropropyl)acetamide, [18F]EF3.
Saved in:
| Title: | Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)-N-(3,3,3-[18F]trifluoropropyl)acetamide, [18F]EF3. |
|---|---|
| Authors: | Mahy, P.1, de Bast, M.1, Leveque, P. H.2,3, Gillart, J.2, Labar, D.2, Marchand, J.4, Gregoire, V.1 gregoire@rbnt.ucl.ac.be |
| Source: | European Journal of Nuclear Medicine & Molecular Imaging. 2004, Vol. 31 Issue 9, p1263-1272. 10p. |
| Database: | Academic Search Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 14262302 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)-N-(3,3,3-[<superscript>18</superscript>F]trifluoropropyl)acetamide, [<superscript>18</superscript>F]EF3. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Mahy%2C+P%2E%22">Mahy, P.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22de+Bast%2C+M%2E%22">de Bast, M.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Leveque%2C+P%2E+H%2E%22">Leveque, P. H.</searchLink><relatesTo>2,3</relatesTo><br /><searchLink fieldCode="AR" term="%22Gillart%2C+J%2E%22">Gillart, J.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Labar%2C+D%2E%22">Labar, D.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Marchand%2C+J%2E%22">Marchand, J.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Gregoire%2C+V%2E%22">Gregoire, V.</searchLink><relatesTo>1</relatesTo><i> gregoire@rbnt.ucl.ac.be</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22European+Journal+of+Nuclear+Medicine+%26+Molecular+Imaging%22">European Journal of Nuclear Medicine & Molecular Imaging</searchLink>. 2004, Vol. 31 Issue 9, p1263-1272. 10p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=14262302 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00259-004-1573-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 10 StartPage: 1263 Titles: – TitleFull: Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)-N-(3,3,3-[18F]trifluoropropyl)acetamide, [18F]EF3. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mahy, P. – PersonEntity: Name: NameFull: de Bast, M. – PersonEntity: Name: NameFull: Leveque, P. H. – PersonEntity: Name: NameFull: Gillart, J. – PersonEntity: Name: NameFull: Labar, D. – PersonEntity: Name: NameFull: Marchand, J. – PersonEntity: Name: NameFull: Gregoire, V. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2004 Type: published Y: 2004 Identifiers: – Type: issn-print Value: 16197070 Numbering: – Type: volume Value: 31 – Type: issue Value: 9 Titles: – TitleFull: European Journal of Nuclear Medicine & Molecular Imaging Type: main |
| ResultId | 1 |